rsv vaccine side effects

GSK, RSV

Sales of GSK’s RSV vaccine down dramatically from last year

Quarterly sales of GSK's RSV vaccine dropped more than 70%, following narrower recommendations for who should get the shot.

Seeking Alpha · 3d

Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is shrinking. Read more here.

Monthly Prescribing Reference · 6d

RSV Vaccine Linked to Better Outcomes in Older Adults With IBD

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

copdnewstoday · 14d

FDA approves first RSV vaccine for at-risk adults younger than 50

The FDA approved RSV vaccine Abrysvo, which protects against lung infections, for high-risk adults as young as 18 with diseases like COPD.

Reuters on MSN · 3d

Canada approves Moderna's RSV vaccine for adults aged 60 and older

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorised mRNA-based shot for the condition.

Toronto Sun · 3d

Health Canada approves Moderna’s mRNA RSV vaccine, company says

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.

The RSV Vaccine for Infants: Everything Parents Need to Know

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Hosted on MSN12d

New RSV vaccine distribution: Who's at the top of the list?

The RSV vaccine isn't needed annually like the flu vaccine ... In adults, the most frequently reported side effects ...

infectiousdiseaseadvisor.com10d

RSV Vaccine Abrysvo Approved for Adults Aged 18 to 59 at Increased Risk

FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.

AL DA News3d

Coming Soon: Respiratory Syncytial Virus (RSV) Vaccine

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

MedPage Today12d

RSV Vaccine 90% Effective in High-Risk Adults, Real-World Study Shows

Opens in a new tab or window The bivalent RSV prefusion F vaccine (Abrysvo ... One way that we mitigated the effects of this kind of limited testing was by salvaging swabs that were used for ...

GlobalData on MSN19d

FDA expands Pfizer’s RSV vaccine label to include all high-risk adults

Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults aged over 18 years.

WSAW2d

Doctors stress the importance of the RSV vaccine

WAUSAU, Wis. (WSAW) --- Doctors recommend that people learn about the RSV vaccine as cold and flu season approaches Wisconsin. RSV, or Respiratory Syncytial Virus, is a common contagious virus ...

4don MSN

It's Safe to Get the COVID-19 and Flu Shots at the Same Time

It’s vaccination season, which for most people means getting immunized for flu and COVID-19 (and RSV for infants, pregnant ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

GSK, RSV

Related topics